Viewing Study NCT00754559


Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-02-02 @ 2:46 PM
Study NCT ID: NCT00754559
Status: COMPLETED
Last Update Posted: 2016-02-08
First Post: 2008-09-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML21469
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators